Researchers warn that patients are missing out on potential benefits due to prohibitive regulations on research into recreational drugs
Hannah Devlin – The Guardian
5th March 2015
Psychedelic drugs could prove to be highly effective treatments for depression and alcoholism, according to scientists who have obtained the first brain scans of people under the influence of LSD.
Early results from the trial, involving 20 people, are said to be “very promising” and add to existing evidence that psychoactive drugs could help reverse entrenched patterns of addictive or negative thinking.
However, Prof David Nutt, who led the study together with Amanda Feilding of the Beckley Foundation, warned that patients are missing out on the potential benefits of such treatments due to prohibitive regulations on research into recreational drugs.
Speaking at a briefing in London, the government’s former chief drugs adviser, said the restrictions amounted to “the worst censorship in the history of science”.
Read the full article here.